International expert consensus recommendations for the diagnosis and treatment of Langerhans cell histiocytosis in adults

G Goyal, A Tazi, RS Go, KL Rech… - Blood, The Journal …, 2022 - ashpublications.org
Langerhans cell histiocytosis (LCH) can affect children and adults with a wide variety of
clinical manifestations, including unifocal, single-system multifocal, single-system pulmonary …

[HTML][HTML] Rosai–Dorfman disease between proliferation and Neoplasia

I Elbaz Younes, L Sokol, L Zhang - Cancers, 2022 - mdpi.com
Simple Summary Rosai–Dorfman disease (RDD) was a benign histiocytic proliferative
disorder rather than a neoplastic process. Emergent molecular studies have shown …

ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition

PG Kemps, J Picarsic, BH Durham… - Blood, The Journal …, 2022 - ashpublications.org
ALK-positive histiocytosis is a rare subtype of histiocytic neoplasm first described in 2008 in
3 infants with multisystemic disease involving the liver and hematopoietic system. This entity …

Immunoglobulin G4-related disease, lymphadenopathy, and lymphoma: histopathologic features and diagnostic approach

JR Bledsoe - Surgical Pathology Clinics, 2023 - surgpath.theclinics.com
Lymphadenopathy occurring in patients with immunoglobulin G4 (IgG4)-related disease,
termed IgG4-related lymphadenopathy, shows morphologic heterogeneity and overlap with …

Malignant histiocytosis comprises a phenotypic spectrum that parallels the lineage differentiation of monocytes, macrophages, dendritic cells, and Langerhans cells

A Ravindran, S Dasari, GJ Ruan, CJ Artymiuk, R He… - Modern Pathology, 2023 - Elsevier
Malignant histiocytoses (MHs), or the 'M group'of the Histiocyte Society classification, are
characterized by neoplastic histiocytes with large pleomorphic nuclei. MH encompasses the …

Cyclin D1 expression in Rosai-Dorfman disease: a near-constant finding that is not invariably associated with mitogen-activated protein kinase/extracellular signal …

S Garces, LJ Medeiros, ML Marques-Piubelli… - Human Pathology, 2022 - Elsevier
Activating mutations in the mitogen-activated protein kinase/extracellular signal–regulated
kinase (MAPK/ERK) pathway have been shown in nearly half of the cases of Rosai-Dorfman …

Strong coexpression of transcription factors PU. 1 and Oct-2 in Rosai-Dorfman disease

KG Kiruthiga, S Younes… - American Journal of …, 2022 - academic.oup.com
Abstract Objectives Rosai-Dorfman disease (RDD) is a rare disorder characterized by the
accumulation of large S100 protein-positive histiocytes that typically exhibit emperipolesis …

Challenges in the histopathologic diagnosis of histiocytic neoplasms

KL Rech, R He - Journal of the National Comprehensive Cancer …, 2021 - jnccn.org
Histiocytic neoplasms, including Langerhans cell histiocytosis (LCH), Erdheim-Chester
disease (ECD), and Rosai-Dorfman disease (RDD), present a diagnostic challenge due to …

B-cell lineage neoplasms transdifferentiating into histiocytic/dendritic cell neoplasms: diversity, differentiation lineage, genomic alterations, and therapy: Report from …

W Xiao, C Amador, JR Cook, M Czader… - American Journal of …, 2023 - academic.oup.com
Objectives To report findings from the 2021 Society for Hematopathology/European
Association for Haematopathology Workshop within the category of B-cell lineage …

Rosai-Dorfman disease of the breast: a clinicoradiologic and pathologic study

Q Wang, K Bradley, M Zhang, S Li, X Li - Human Pathology, 2023 - Elsevier
Rosai-Dorfman disease (RDD) is an uncommon histiocytic disorder typically involving lymph
nodes and less frequently extranodal tissues. RDD involving the breast is rare and may …